TherapeuticsMD, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $1.15M.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $2.45M, a 92.29% decline year-over-year.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $31.82M.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $163.00K.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for fiscal 2023 was $3.15M, a 28.36% increase from fiscal 2022.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for fiscal 2022 was $2.45M, a 98.67% decline from fiscal 2021.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for fiscal 2021 was $184.12M, a 480.75% increase from fiscal 2020.
- TherapeuticsMD, Inc. stock issued during period, value, new issues for fiscal 2020 was $31.70M, a 58.84% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $3.15M 10-K · filed 2025-03-27 | |
| 2023-06-30 | $1.15M 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $2.45M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $2.45M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $184.12M 10-K · filed 2023-04-07 | |
| 2021-09-30 | $31.82M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $163.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $150.90M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $31.70M 10-K · filed 2022-03-23 | |
| 2019-12-31 | $77.03M 10-K · filed 2022-03-23 | |
| 2018-12-31 | $89.91M 10-K · filed 2021-03-04 | |
| 2018-09-30 | $89.91M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $68.57M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $134.86M 10-K · filed 2019-02-27 | |
| 2015-12-31 | $91.37M 10-K · filed 2018-02-23 | |
| 2014-12-31 | $42.77M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $78.65M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $7.90M 10-K · filed 2015-03-12 | |
| 2011-12-31 | $1.71M 10-K · filed 2014-03-05 | |
| 2010-12-31 | $3.17M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |